CA
CELG

Calton & Associates’s Celgene Corp CELG Stock Holding History

Calton & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,167
Closed -$612K – 401
2019
Q3 		$612K Buy
6,167
+890
+17% +$84.6K 0.14% 133
2019
Q2 		$488K Buy
5,277
+456
+9% +$43.3K 0.14% 132
2019
Q1 		$455K Buy
4,821
+479
+11% +$41.9K 0.14% 145
2018
Q4 		$278K Buy
4,342
+104
+2% +$7.68K 0.1% 175
2018
Q3 		$379K Buy
4,238
+1
+0% +$88 0.11% 158
2018
Q2 		$387K Sell
4,237
-706
-14% -$58.6K 0.11% 147
2018
Q1 		$441K Buy
4,943
+441
+10% +$42.3K 0.13% 171
2017
Q4 		$470K Buy
+4,502
New +$508K 0.12% 172

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Calton & Associates's CELG Position: Q4 2019 in Review

Calton & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,167 shares — an estimated $612K sold.

Calton & Associates first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $612K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Calton & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Calton & Associates sold 6,167 Celgene Corp shares in Q4 2019, an estimated $612K.
  • Calton & Associates first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Calton & Associates's Celgene Corp position peaked at $612K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Calton & Associates's 13F filing for Q4 2019, filed 3 Feb 2020.